|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 886.6 DKK | +2.28% |
|
+2.36% | +27.00% |
| Apr. 25 | NOVO NORDISK : JP Morgan gives a Buy rating | ZD |
| Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
FRANKFURT, March 25 (Reuters) - Novo Nordisk said it plans to seek coverage by Germany's public health insurance scheme for the use of its Wegovy drug to cut the risk of strokes and heart attacks, if the drug's extended indication wins European approval.
(Reporting by Ludwig Burger; editing by Jason Neely)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 886.6 DKK | +2.28% | +2.36% | 566B | ||
| 733.5 USD | +1.19% | +0.99% | 661B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +27.00% | 566B | |
| +25.83% | 661B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B | |
| -11.77% | 144B |
NOVO NORDISK A/S 
